Expanding Our Presence in Georgia with Gemcitabine
Venus Remedies Limited has received MA for Gemcitabine in Georgia, marking another milestone in its global expansion.
In the pharma landscape, each new market authorization represents more than regulatory progress. It reflects the sustained efforts behind research, manufacturing excellence, quality systems, and international collaboration that enable us to take trusted healthcare solutions to new geographies.
Likewise, Venus Remedies Limited continues to advance its global journey with another important milestone in the oncology space. With the marketing authorization of Gemcitabine in Georgia, we are further strengthening our presence in international markets while expanding the reach of our specialized oncology portfolio.
Gemcitabine’s Role in Cancer Care
Gemcitabine is an established chemotherapy medicine used in the treatment of several types of cancer. It is used in therapeutic regimens for cancers including pancreatic, lung, breast and ovarian cancer, making it an important component of oncology care.
Cancer continues to place a significant burden on healthcare systems worldwide, making access to dependable and quality treatment options increasingly important. Through continued expansion into new markets, we aim to support healthcare ecosystems with specialised injectable therapies designed to address critical medical needs.
For Venus Remedies, the authorisation in Georgia also strengthens our presence in the wider European region and adds momentum to our long-term international growth strategy.
Continuing the Journey Forward
The approval of Gemcitabine in Georgia is another meaningful addition to Venus Remedies’ growing global presence. As we continue to explore new opportunities across international markets, our focus remains firmly on innovation, regulatory excellence and the development of specialised healthcare solutions.
We remain committed to strengthening our oncology portfolio and expanding access to quality medicines in markets around the world.
“With every new authorization, we take another step forward—strengthening our global presence and moving closer to our vision of delivering trusted healthcare solutions wherever they are needed, says Aditi K. Chaudhary, President, International Business, Venus Remedies Limited.
